$CINT

Cint Brings In-Flight Outcomes Measurement to Lucid Measurement

Cint said it has added “in-flight outcomes measurement” to its Lucid Measurement platform, aiming to link brand lift and sales lift in a single dashboard while campaigns are still running. After a closed beta, the feature is in open beta in the U.S., using exposed/control methods and Affinity Solutions behavioral transaction data. Partners include Big Happy, Cognitiv, Roblox, Teads, TripleLift, LG Ads, and WunderKIND Ads.

Original reporting
Published Jun 17, 2026, 1:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 2:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cint Brings In-Flight Outcomes Measurement to Lucid Measurement — source image
Decision brief

The 30-second read

$CINTBullishLow
01

Why it matters

The announcement targets a key advertiser pain point—disparate measurement frameworks—by consolidating brand and sales outcomes into one in-flight dashboard using exposed/control methodology and behavioral transaction data.

02

Market read

A new measurement capability may improve advertiser decision-making and campaign optimization, but the article lacks financial KPIs to gauge magnitude.

03

What to watch

Actual commercial traction (number of paying customers, pricing, retention) and whether Affinity Solutions data access is a bottleneck could determine impact.

Relevance 5/10Novelty 6/10Timing: open beta testing in the United States (announced today)

Background

Lucid Measurement is Cint’s platform for continuous research and media measurement; the new feature aims to connect upper-funnel brand lift with lower-funnel sales lift while campaigns are still live.

Company-level read

Ticker impact

$CINTBullishMedium confidence
Context

Cint launched in-flight outcomes measurement in Lucid Measurement, expanding brand-lift and sales-lift reporting via open beta in the US.

Expected impact

Near-term impact likely modest unless investors view it as meaningful revenue acceleration; watch for customer adoption signals.

Evidence & confidence

The article is a first report of a new capability (open beta) but provides no financial metrics, guidance, or adoption scale, limiting immediate valuation impact.

Market effects

Could increase competitive pressure on ad measurement vendors to unify brand and sales outcomes in real time.

US open beta may accelerate adoption among US advertisers and measurement buyers.

If successful, the workflow could be rolled out beyond the US, affecting global measurement spend allocation.

Counterpoint

Open beta with select partners may not translate into material revenue quickly; advertisers may already have multi-vendor stitching workflows.

Key entities

  • Cint

    Introduced in-flight outcomes measurement within Lucid Measurement; open beta in the US after a closed beta.

  • Lucid Measurement

    Cint’s measurement platform being expanded to include outcomes measurement linking brand lift and sales lift.

  • Affinity Solutions

    Provides behavioral transaction data used to connect ad exposure to sales lift.

  • TripleLift

    Early partner using the solution for live optimization across creatives, targeting tactics, and DSPs.

Related articles

$CINTMedAI 8/10

CI&T (CINT) Q2 2026 Earnings Call Transcript

CI&T (CINT) reported Q2 2026 revenue of $142.8M, up 21.9% YoY, exceeding guidance. Full-year revenue guidance raised to $566M-$578M. Adjusted EBITDA was $19M with a 13.3% margin. Sales pipeline expanded 40% YoY, driven by AI demand. Financial services and tech/telecom verticals grew 36% and 68% YoY, respectively. Consumer goods revenue declined 9% YoY. Management highlighted investments in AI and value-based pricing models.

MedAI 8/10

CI&T Inc Q2 2026 Earnings Call Summary

CI&T Inc reported Q2 2026 results and said record revenue growth reflects a shift to AI deployments and value-based pricing. Adjusted gross margin rose to 32.4%. Full-year revenue guidance was raised to $566 million to $578 million, with adjusted EBITDA margin at 15% to 17% amid FX headwinds and planned AI investments.

$CAPRHighAI 8/10

Why Did CAPR Stock Jump 20% After-Hours Today?

Capricor Therapeutics (CAPR) shares rose 20% after-hours on positive Hope-3 extension data showing slower upper-limb deterioration in patients treated with Deramiocel. The FDA is reviewing the data for a Nov. 22 decision. CAPR closed at $8.57, down 2% for the day and 14% for the month. Analysts and retail traders anticipate potential upside ahead of the FDA decision.

$CAPRHighAI 8/10

Capricor jumps as study shows longer-term effects of deramiocel (CAPR:NASDAQ)

Capricor Therapeutics (CAPR) shares rose after presenting data on deramiocel, its experimental Duchenne muscular dystrophy treatment, at the World Muscle Society Congress. The data showed longer-term effects of the therapy, prompting investor interest. According to the company, this could be a significant development for its pipeline. Investors reacted positively to the news, driving up the stock price in late trading Tuesday.

$HOODMedAI 8/10

Robinhood at HOOD Summit ’26: pushes trading into living hours

Robinhood (HOOD) announced plans to expand trading hours to 24/7 for U.S. equities and extend options trading by 35%. The company introduced new AI tools, intraday margin, and perpetual futures. Robinhood also launched an ecosystem of third-party data apps and social trading features. The changes aim to increase market access and trading flexibility for retail investors. According to Robinhood, the shifts are enabled by regulatory approvals and partnerships with exchanges.